Company Financials

Beijing Hotgen Biotech Co. Ltd Financials

Renminbi

business Beijing Hotgen Biotech Co. Ltd Company Profile

Main Stock Listing

SSE: 688068

Market Capitalization CN¥16.25 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 17.29
Forward PE
Price to Sales TTM CN¥34.57
Price to Book MRQ CN¥4.91
Enterprise to Revenue 30.72
Enterprise to EBITDA -124.66

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin -59.69%
Operating Margin -40.36%
Return on Assets TTM -3.94%
Return on Equity TTM -8.52%

Income Statement

Revenue TTM CN¥434,446,208
Revenue per Share TTM CN¥4.85
Quarterly Revenue Growth -23.00%
Gross Profit TTM CN¥221,653,984
EBITDA CN¥-107,050,296
Net Income to Common TTM CN¥-259,325,440
Diluted EPS TTM CN¥-2.92
Quarterly Earnings Growth YoY -16.59%

Balance Sheet

Total Cash MRQ CN¥1,093,134,720
Total Cash per Share MRQ CN¥12.31
Total Debt MRQ CN¥
Total Debt to Equity MRQ 1.71
Current Ratio MRQ 5.07
Book Value per Share MRQ CN¥33.01

Cash Flow

Operating Cash Flow TTM CN¥-26,341,584
Levered Free Cash Flow TTM CN¥62,924,816

688068 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 92,707,940
Float Shares 60,730,347
Avg 10 Volume 1,433,627
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 32.34%
% Held by Institutions 25.38%

Stock Price Summary

Beta 1.69
Fifty Two Week Low CN¥56.69
Fifty Two Week High CN¥262.22
Fifty Two Week Change 58.06%
Day 50 MA CN¥166.80
Day 200 MA CN¥162.54

Dividends and Splits

Forward Annual Dividend Rate CN¥0.20
Forward Annual Dividend Yield 0.14%
Trailing Annual Dividend Rate CN¥0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2024-07-03
Last Split Factor
Last Split Date 2022-06-16